Spin-off news
Here you can find news from MPG spin-off companies.
Alnylam
Blackstone and Alnylam Close $150 Million R&D Financing to Advance RNAi Therapeutics for Cardiovascular Disease
Dewpoint Therapeutics
Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV
Alnylam
Alnylam Submits CTA Application for ALN-HSD, an Investigational RNAi Therapeutic for the Treatment of Nonalcoholic Steatohepatitis (NASH)